AbbVie ABBV Ratios (2012-2026)

NYSE ABBV
$261.89 -1.40 (-0.53%)
As of: Sep 30, 2026 · 3:51 PM EDT
Reported Financials

AbbVie Quarterly Ratios

Periods 58 quarters
Latest Jun 2026

AbbVie reported a gross margin of 74.74% and a net margin of 21.27% for the quarter ended Jun 2026. These financial ratios cover 58 quarters of results from Mar 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
69.39%70.98%70.07%71.41%66.10%72.42%67.39%69.42%53.44%60.11%66.74%70.94%70.87%70.89%70.01%71.82%66.38%72.61%71.88%74.74%
EBT Margin
25.71%28.69%36.41%8.11%29.71%19.61%3.89%18.82%14.02%8.47%14.26%14.84%14.41%-15.02%12.45%10.08%4.53%16.05%6.93%25.18%
EBIT Margin
30.02%34.09%34.84%22.59%31.08%36.39%22.64%32.55%16.38%22.34%22.73%27.64%26.49%-9.87%27.98%31.73%12.07%27.34%26.60%37.86%
EBITDA Margin
44.83%47.38%50.34%36.33%45.80%50.72%40.04%49.07%32.15%36.56%39.65%42.06%40.95%4.05%43.57%45.26%25.33%39.40%39.50%49.01%
Operating Margin
30.02%34.09%34.84%22.59%31.08%36.39%22.64%32.55%16.38%22.34%22.73%27.64%26.49%-9.87%27.98%31.73%12.07%27.34%26.60%37.86%
Net Margin
22.17%27.17%33.17%6.34%26.66%16.35%1.96%14.60%12.77%5.75%11.12%9.47%10.80%-0.15%9.64%6.08%1.18%10.93%4.63%21.27%
FCF Margin
53.81%32.84%35.06%33.34%50.13%47.72%32.87%44.29%52.81%31.80%31.25%14.04%35.95%44.74%10.49%31.67%42.11%29.42%23.76%18.33%
Efficiency
Inventory AverageInventory Avg.
3.24B3.11B3.31B3.44B3.28B3.38B3.71B3.94B4.02B4.04B4.17B4.23B4.33B4.32B4.35B4.74B4.95B4.94B5.00B5.09B
Assets AverageAssets Avg.
148.41B147.69B144.87B143.20B142.26B140.06B136.67B134.96B135.79B135.47B141.79B145.41B142.68B139.29B135.66B136.67B135.54B133.93B135.21B135.79B
Equity AverageEquity Avg.
13.09B14.51B15.88B15.50B15.36B16.66B15.29B13.10B12.51B11.26B9.22B7.43B6.45B4.72B2.41B0.66B-1.39B-2.96B-4.94B-6.27B
Invested CapitalInvested Cap.
94.30B92.12B89.79B87.62B85.63B80.56B75.40B73.91B72.88B69.78B82.05B77.45B77.15B70.51B71.35B70.34B66.10B64.23B66.25B64.89B
Asset Utilization RatioAsset Util.
0.370.380.390.400.410.410.420.420.410.400.380.380.390.400.420.430.440.460.460.47
Leverage & Solvency
Interest Coverage RatioInterest Cover
Debt Ratio
0.540.520.510.510.490.460.460.450.450.440.500.500.500.500.510.510.510.500.530.52
Times Interest Earned
Valuation
Price to EarningsP/E
25.3120.7522.9621.4317.7024.1637.0727.3840.4056.2953.6656.7568.1373.3388.2287.14171.3795.60105.7170.47
Price to SalesP/S
3.464.265.054.724.114.934.964.244.775.045.915.516.285.576.455.626.866.616.126.91
Price to BookP/B
14.0515.5117.5618.4414.8116.5421.1418.4421.7026.3339.9644.4257.4893.25253.14
Enterprise Value
178.48B229.69B278.93B260.88B225.50B276.76B274.48B229.07B249.92B260.97B303.54B289.85B341.73B308.19B364.96B321.49B403.59B398.79B374.91B438.16B
EV to EBIT
10.7512.8115.0515.0012.7515.2816.9813.1816.5920.4623.7423.6224.7233.7336.2429.3144.6426.4524.4525.97
EV to EBITDA
7.098.6910.3510.198.6910.4211.148.7610.4812.1914.1914.0215.4517.6119.8016.6323.1917.0915.9917.67
Market Capitalization
190.70B239.49B286.47B270.80B237.35B285.95B281.17B237.80B263.17B273.75B321.56B302.96B348.97B313.70B370.10B327.91B409.22B404.01B384.26B444.68B
Price to FCFP/FCF
8.8010.8912.9912.1910.8311.7911.959.5910.6412.4114.6917.0422.3417.5924.0617.9820.7922.6819.2324.42
EV to FCF
8.2310.4512.6511.7410.2911.4111.679.2410.1111.8313.8716.3021.8717.2823.7217.6320.5022.3818.7624.06
EV to CFO
7.9110.0812.2311.389.9811.1011.338.979.8011.4313.3815.5520.7016.3922.2516.6719.3520.9617.6622.46
Return Ratios
Return on Sales [ROS]ROS
30.02%34.09%34.84%22.59%31.08%36.39%22.64%32.55%16.38%22.34%22.73%27.64%26.49%-9.87%27.98%31.73%12.07%27.34%26.60%37.86%
Return on Capital Employed [ROCE]ROCE
13.85%15.93%16.50%16.00%16.15%16.39%14.82%16.93%14.91%13.07%12.75%11.86%13.88%9.09%10.15%11.32%9.40%16.63%16.47%17.92%
Return on Invested Capital [ROIC]ROIC
17.57%17.10%18.11%17.62%18.53%19.16%19.32%16.18%13.20%13.43%11.65%12.75%12.38%14.20%15.48%13.25%14.84%14.32%18.68%
Return on Assets [ROA]ROA
5.08%7.82%8.62%8.83%9.43%8.46%5.56%6.44%4.80%3.60%4.23%3.68%3.60%3.08%3.10%2.76%1.77%3.16%2.69%4.65%
Return on Equity [ROE]ROE
57.64%79.61%78.66%81.58%87.37%71.11%49.64%66.35%52.11%43.27%65.11%71.97%79.63%90.85%174.18%569.64%

AbbVie Ratios API

Pull AbbVie's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ABBV&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY